Evidence map›Paper›PMID 33981474›Full record

ReviewKidney international supplements2021

International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Oceania and South East Asia.

Isabelle Ethier, David W Johnson, Aminu K Bello, Feng Ye, Mohamed A Osman, Adeera Levin, David C H Harris, Peter Kerr, Adrian Liew, Muh Geot Wong and 9 more

Open access · greenAbstract readReview
In one paragraph

Review in Kidney international supplements, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Global Kidney Health Atlas: a spotlight on the Asia-Pacific sector.Kidney research and clinical practice · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 6 countries.

Isabelle EthierDepartment of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
David W JohnsonDepartment of Nephrology, Metro South and Ipswich Nephrology and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Aminu K BelloDivision of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Feng YeDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Mohamed A OsmanDepartment of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Adeera LevinDivision of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
David C H HarrisCentre for Transplantation and Renal Research, The Westmead Institute for Medical Research, University of Sydney, Westmead, New South Wales, Australia.
Peter KerrNephrology, Monash Medical Centre, Victoria, Australia.
Adrian LiewThe Kidney & Transplant Practice, Mount Elizabeth Novena Hospital, Singapore.
Muh Geot WongDepartment of Renal Medicine, Royal North Shore Hospital, University of Sydney, New South Wales, Australia.
Meaghan LunneyDepartment of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Syed SaadDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Deenaz ZaidiDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Maryam KhanFaculty of Science, University of Alberta, Edmonton, Alberta, Canada.
Vivekanand JhaGeorge Institute for Global Health, University of New South Wales, New Delhi, India.
Marcello TonelliDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Ikechi G OkpechiDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Andrea K ViecelliDepartment of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
ISN Oceania and South East Asia Regional Board
University of Alberta · CAPrincess Alexandra Hospital · AUThe University of Sydney · AUUniversity of Calgary · CAManipal Academy of Higher Education · INMonash Medical Centre · AUMount Elizabeth Novena Hospital · SGThe University of Queensland · AUUniversity of British Columbia · CAUniversity of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oceania and South East Asia (OSEA) is a socioeconomically, culturally, and ethnically diverse region facing a rising epidemic of noncommunicable diseases, including chronic kidney disease (CKD). The second iteration of the International Society of Nephrology Global Kidney Health Atlas aimed to provide a comprehensive evaluation of kidney care in OSEA. Of the 30 countries/territories in OSEA, 15 participated in the survey, representing 98.5% of the region's population. The median prevalence of treated kidney failure in OSEA was 1352 per million population (interquartile range, 966-1673 per million population), higher than the global median of 787 per million population. Although the general availability, access, and quality of kidney replacement therapy (i.e., dialysis and transplantation) was high in OSEA, inequalities in accessibility and affordability of kidney replacement therapy across the region resulted in variability between countries. According to the survey results, in a third of the participating countries (mostly lower-income countries), less than half the patients with kidney failure were able to access dialysis, whereas it was readily available to all with minimal out-of-pocket costs in high-income countries; similar variability in access to transplantation was also recorded. Limitations in workforce and resources vary across the region and were disproportionately worse in lower-income countries. There was little advocacy for kidney disease, moderate use of registries, restricted CKD detection programs, and limited availability of routine CKD testing in some high-risk groups across the region. International collaborations, as seen in OSEA, are important initiatives to help close the gaps in CKD care provision across the region and should continue receiving support from the global nephrology community.

Indexed as

dialysisend-stage kidney diseaseglobal health carehealth care deliveryhealth policynephrologyOceania and South East Asiasurveys and questionnaires

Identifiers

PMID33981474
PMCPMC8084715
OpenAlexW4243558701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.